The power of ideas through the development of innovative research tools
News
- Andy Sheldon Named CEO of the Year by Vaccine Industry Excellence Awards
- The first CQDM funded project is a remarkable success – Thanks to CQDM funding, Medicago announces an important investment in Québec
- Harnessing nanotechnology in the fight against cancer - Sylvain Martel
- CQDM will receive a grant from the BL-NCE to research better ways of developing and testing drugs that treat central nervous system diseases
- CQDM is proud to announce an investment of $1.5 M in two collaborative projects from the Québec/Ontario corridor
- The CQDM and Univalor have announced a collaboration agreement
- Caprion Protéomique: la rentabilité avant les découvertes
The Québec Consortium for Drug Discovery (CQDM) is a meeting ground for all stakeholders in biopharmaceutical research and whose principal mission is to fund research projects carried out in partnership between the academic and hospital milieus in the public sector and the pharmaceutical and biotechnology industries in the private sector.
An innovative Canadian initiative, CQDM has a twofold goal: to accelerate the drug discovery process and to develop safer and more effective drugs.
Established under an innovative public-private partnership model, CQDM puts the needs of the pharmaceutical industry at the very centre of its concerns.
